Keywords

On this page readers can obtain a listing of documents classified by keywords. Click on the bookshelf icon of a keyword to obtain the concerned documents or to return to the main list of keywords.
All - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z
Expand the sub-collections menu.
79 documents on 1 page
 
 
 
Open this document and view its content

A70/23 - Dispositif des États Membres concernant les produits médicaux de qualité inférieure/faux/ faussement étiquetés/falsifiés/contrefaits. Rapport du Directeur général. Soixante-Dixième Assemblée mondiale de la Santé, 2017. (inclus : A70/23 Add.1 - Examen du dispositif des États Membres concernant les produits médicaux de qualité inférieure/faux/faussement étiquetés/falsifiés/contrefaits) (avec Appendice 1: Orientations pour l’élaboration d’un plan national en vue de prévenir, de détecter et de combattre les mesures, activités et comportements à l’origine de produits médicaux de qualité inférieure/faux/faussement étiquetés/falsifiés/contrefaits. Appendice 2: Technologies d’authentification disponibles pour la prévention et la détection des produits médicaux de qualité inférieure/faux/faussement étiquetés/falsifiés/contrefaits. Appendice 3: Dispositif OMS des États Membres concernant les produits médicaux de qualité inférieure/faux/faussement étiquetés/falsifiés/contrefaits: Définitions de travail) [Arabic] [Chinese] [English] [Russian] [Spanish]

Year:

2017;

Pages:

46;


Related documents:

Regions:

 
Open this document and view its content

A70/23 - Mecanismo de Estados Miembros sobre productos médicos de calidad subestándar, espurios, de etiquetado engañoso, falsificados o de imitación. Informe de la Directora General. La 70.ª Asamblea Mundial de la Salud, 2017. (incluido A70/23 Add.1 - Examen del mecanismo de Estados Miembros sobre productos médicos de calidad subestándar, espurios, de etiquetado engañoso, falsificados o de imitación) (con Apéndice 1: Orientaciones sobre la elaboración de un plan nacional para prevenir, detectar y contrarrestar las medidas, actividades y comportamientos que originan productos médicos de calidad subestándar, espurios, de etiquetado engañoso, falsificados o de imitación (SSFFC). Apéndice 2: Tecnologías de autenticación disponibles para la prevención y la detección de productos médicos SSFFC. Apéndice 3: Mecanismo de estados miembros de la oms sobre productos médicos de calidad subestándar, espurios, de etiquetado engañoso, falsificados o de imitación (SSFFC): Definiciones funcionales) [Arabic] [Chinese] [English] [French] [Russian]

Year:

2017;

Pages:

44;


Related documents:

Regions:

 
Open this document and view its content

A70/23 - Member State Mechanism on Substandard/Spurious/Falsely-labelled/Falsified/ Counterfeit Medical Products. Report by the Director-general. Seventieth World Health Assembly, 2017. (With A70/23 Add.1 - Review of the Member State Mechanism On Substandard/Spurious/Falsely-labelled/ Falsified/Counterfeit Medical Products) (with Appendix 1: Guidance on Developing a National Plan for Preventing, Detecting and Responding to Actions, Activities and Behaviours That Result in Substandard/Spurious/Falsely-labelled/Falsified/Counterfeit (Ssffc) Medical Products. Appendix 2: Available Authentication Technologies for the Prevention and Detection of (Ssffc) Medical Products. Appendix 3: Who Member State Mechanism on Substandard/Spurious/Falsely-labelled/Falsified/Counterfeit (Ssffc) Medical Products: Working Definitions) [Arabic] [Chinese] [French] [Russian] [Spanish]

Year:

2017;

Pages:

42;


Related documents:

Regions:

 
Open this document and view its content

A70/23 - Member State mechanism on substandard/spurious/falsely-labelled/falsified/ counterfeit medical products. Report by the Director-General. Seventieth World Health Assembly, 2017. (with A70/23 Add.1 - Review of the Member State mechanism on substandard/spurious/falsely-labelled/ falsified/counterfeit medical products) (with Appendix 1: Guidance on developing a national plan for preventing, detecting and responding to actions, activities and behaviours that result in substandard/spurious/falsely-labelled/falsified/counterfeit (SSFFC) medical products. Appendix 2: Available authentication technologies for the prevention and detection of (SSFFC) medical products. Appendix 3: WHO member state mechanism on substandard/spurious/falsely-labelled/falsified/counterfeit (SSFFC) medical products: Working definitions) (Arabic version) [Chinese] [English] [French] [Russian] [Spanish]

Year:

2017;

Pages:

45;


Related documents:

Regions:

 
Open this document and view its content

A70/23 - Member State mechanism on substandard/spurious/falsely-labelled/falsified/ counterfeit medical products. Report by the Director-General. Seventieth World Health Assembly, 2017. (with A70/23 Add.1) (Chinese version) A70/23 - 劣质、假造、标签不当、伪造、假冒 医疗产品问题会员国机制. 总干事的报告. 第七十届世界卫生大会, 2017. (A70/23 Add.1) (Chinese version) -关于劣质、假造、标签不当、伪造、假冒医疗产品问题会员国机制第五次会议的报告. 附录1 关于制定国家计划预防、发现和应对导致劣质、假造、标签不当、伪造、 假冒医疗产品的行动、活动和行为的指导. 附录2 预防和发现劣质、假造、标签不当、伪造、假冒医疗产品的现有认证技术. 附录3劣质、假造、标签不当、伪造、假冒医疗产品问题世卫组织会员国机制. 工作定义 [Arabic] [English] [French] [Russian] [Spanish]

Year:

2017;

Pages:

47;


Related documents:

Regions:

 
Open this document and view its content

A70/23 - Member State mechanism on substandard/spurious/falsely-labelled/falsified/ counterfeit medical products. Report by the Director-General. Seventieth World Health Assembly, 2017. (with A70/23 Add.1) (Russian version) A70/23 - МЕХАНИЗМ ГОСУДАРСТВ-ЧЛЕНОВ ПО НЕКОНДИЦИОННОЙ/ПОДДЕЛЬНОЙ/ЛОЖНО МАРКИРОВАННОЙ/ФАЛЬСИФИЦИРОВАННОЙ/ КОНТРАФАКТНОЙ МЕДИЦИНСКОЙ ПРОДУКЦИИ. ДОКЛАД ГЕНЕРАЛЬНОГО ДИРЕКТОРА. СЕМИДЕСЯТАЯ СЕССИЯ ВСЕМИРНОЙ АССАМБЛЕИ ЗДРАВООХРАНЕНИЯ, 2017. ВКЛЮЧЕНЫ (A70/23 Add.1) ДОБАВЛЕНИЕ 1 РУКОВОДСТВО ПО РАЗРАБОТКЕ НАЦИОНАЛЬНОГО ПЛАНА ПО ПРЕДОТВРАЩЕНИЮ, ВЫЯВЛЕНИЮ И ПРЕСЕЧЕНИЮ МЕР, ВИДОВ ДЕЯТЕЛЬНОСТИ И ФОРМ ПОВЕДЕНИЯ, КОТОРЫЕ ПРИВОДЯТ К СОЗДАНИЮ НЕКОНДИЦИОННОЙ/ПОДДЕЛЬНОЙ/ЛОЖНО МАРКИРОВАННОЙ/ФАЛЬСИФИЦИРОВАННОЙ/КОНТРАФАКТНОЙ МЕДИЦИНСКОЙ ПРОДУКЦИИ (НПЛФК). ДОБАВЛЕНИЕ 2 ИМЕЮЩИЕСЯ ТЕХНОЛОГИИ АУТЕНТИФИКАЦИИ В ИНТЕРЕСАХ ПРЕДОТВРАЩЕНИЯ ПОЯВЛЕНИЯ НА РЫНКЕ И ВЫЯВЛЕНИЯ МЕДИЦИНСКОЙ ПРОДУКЦИИ НПЛФК ДОБАВЛЕНИЕ 3 МЕХАНИЗМ ГОСУДАРСТВ-ЧЛЕНОВ ВОЗ ПО НЕКОНДИЦИОННОЙ/ПОДДЕЛЬНОЙ/ЛОЖНО МАРКИРОВАННОЙ/ФАЛЬСИФИЦИРОВАННОЙ/КОНТРАФАКТНОЙ МЕДИЦИНСКОЙ ПРОДУКЦИИ (НПЛФК). РАБОЧИЕ ОПРЕДЕЛЕНИЯ [Arabic] [Chinese] [English] [French] [Spanish]

Year:

2017;

Pages:

54;


Related documents:

Regions:

 
Open this document and view its content

Addressing the Barriers to Effective Monitoring, Reporting and Containment of Spurious/Substandard/Falsely-labelled/ Falsified/Counterfeit Medical Products through Sustainable Multi-stakeholder Collaboration and Community/Consumer-based Interventions. A report prepared for the Medicines Transparency Alliance, Philippines

Year:

2016;

Pages:

94;


Related documents:

Countries:

 
Open this document and view its content

An Assessment of Global Chemistry, Manufacturing and Controls (CMC) Regulatory Requirements in Low and Middle Income Countries. (WHO Drug Information Vol. 32, No. 3, 2018)

Year:

2018;

Pages:

7;


Related documents:

Regions:

 
Open this document and view its content

Collaborative Procedure Between the World Health Organization (WHO) Prequalification Team and National Regulatory Authorities in the Assessment and Accelerated National Registration of WHO-prequalified Pharmaceutical Products and Vaccines. WHO Technical Report Series, No. 996, 2016, Annex 8

Year:

2016;

Pages:

42;


Related documents:

Regions:

 
Open this document and view its content

Collaborative Procedure in the Assessment and Accelerated National Registration of Pharmaceutical Products and Vaccines Approved by Stringent Regulatory Authorities. WHO Technical Report Series, No. 1010, 2018, Annex 11

Year:

2018;

Pages:

54;


Regions:

 
Open this document and view its content

Drug Registration Guidance 2073. (Issued under Drug Registration Regulation 2038). MOH, Nepal, 2016

Year:

2016;

Pages:

177;


Countries:

 
Open this document and view its content

Good Practices of National Regulatory Authorities in Implementing the Collaborative Registration Procedures for Medical Products. WHO Technical Report Series, No. 1019, 2019, Annex 6

Year:

2019;

Pages:

53;


Related documents:

Regions:

 
Open this document and view its content

Guideline for Registration of Medicines. Third Edition, June 2014 - Ethiopia

Year:

2014;

Pages:

141;


Countries:

 
Open this document and view its content

Guidelines for Conducting Clinical Trials - Sierra Leone

Year:

2013;

Pages:

14;


Countries:

 
Open this document and view its content

Guidelines for Conducting Clinical Trials of Medicines, Food Supplements, Vaccines and Medical Devices in Sierra Leone

Year:

2014;

Pages:

32;


Countries:

 
Open this document and view its content

Guidelines for Medicinal Product Registration - Sierra Leone

Year:

2013;

Pages:

28;


Related documents:

Countries:

 
Open this document and view its content

Legislación reglamentaria nacional en materia de fármacos: Principios orientadores para pequeños servicios de reglamentación farmacéutica. OMS, Serie de Informes Técnicos, No. 885, 1999, Annex 8 [English]

Year:

1999;

Pages:

44;


Related documents:

Regions:

 
Open this document and view its content

Lignes directrices pour la préparation et la soumission de dossiers en format document technique commun. Septembre 2015 - République démocratique du Congo

Year:

2015;

Pages:

33;


Related documents:

 
Open this document and view its content

Lignes directrices relatives a l’homologation des médicaments à base des plantes. Septembre 2015 - République démocratique du Congo

Year:

2015;

Pages:

18;


 
Open this document and view its content

Lignes directrices relatives au dépôt des demandes d’enregistrement au format CTD (common technical document) : qualité. Septembre 2015 - République démocratique du Congo

Year:

2015;

Pages:

62;


Related documents:

 
Open this document and view its content

MOH Guidelines on Submission of Documentation for Registration of Human Pharmaceutical Products. First Edition, 2014 - Republic of Rwanda

Year:

2014;

Pages:

436;


Countries:

 
Open this document and view its content

National Drug Regulatory Legislation: Guiding Principles for Small Drug Regulatory Authorities. WHO Technical Report Series, No. 885, 1999, Annex 8 [Spanish]

Year:

1999;

Pages:

41;


Related documents:

Regions:

 
Open this document and view its content

Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries. A Systematic Review and Meta-analysis

Year:

2018;

Pages:

22;

Related documents:

Regions:

 
Open this document and view its content

Rapid Evaluation of the Medicines Registration System in Benin. November 2016

Year:

2016;

Pages:

24;


Related documents:

Countries:

 
Open this document and view its content

Situation Analysis: Introducing Pharmaceutical Product Registration Policy in Angola. July 2016

Author:

Year:

2016;

Pages:

22;


Related documents:

Countries:

 
Open this document and view its content

A Study on the Public Health and Socioeconomic Impact of Substandard and Falsified Medical Products

Year:

2017;

Pages:

77;


Related documents:

Regions:

 
Open this document and view its content

WHO Global Surveillance and Monitoring System for Substandard and Falsified Medical Products

Year:

2017;

Pages:

73;


Related documents:

Regions:

 
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 1, 2019